Annual health care resource utilization and cost among type 2 diabetes patients with newly recognized chronic kidney disease within a large U.S. administrative claims database
Kerstin Folkerts(Bayer (Germany)), Csaba P. Kövesdy(University of Tennessee Health Science Center), Linda F. Fried(VA Pittsburgh Healthcare System), Alain Gay(Bayer (Germany)), Amanda Kelly(University of Tennessee Health Science Center), Michael Blankenburg(Bayer (Germany)), Natalia Petruski‐Ivleva(AVEO Oncology (United States))
Cited by 50
Related Papers
Obesity and Kidney Disease: Hidden Consequences of the Epidemic
|American Journal of Nephrology|2017|2.2k
Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits
|Nature Genetics|2018|1.5k
Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality
|JAMA|2014|982
Development and Validation of the American Heart Association’s PREVENT Equations
|Circulation|2023|935
A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
|Kidney International|2019|886